Monopar Therapeutics (MNPR) Other Working Capital Changes (2021 - 2025)

Monopar Therapeutics has reported Other Working Capital Changes for 9 years, with the latest figure at -$709403.0 in Q4 2025.

• Quarterly Other Working Capital Changes fell 2484.39% year-over-year to -$709403.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15404.0 (down 220.57% YoY) and the FY2025 annual result came in at -$15404.0, down 220.57% from the prior year.
• Other Working Capital Changes retreated to -$709403.0 in Q4 2025 per MNPR's latest filing, from $107242.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $621543.0 in Q1 2025 and troughed at -$709403.0 in Q4 2025.
• A 5-year average of -$12008.6 and a median of -$8273.5 in 2022 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 3720.59% in 2025, down 2484.39% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$42087.0 in 2021, then surged by 76.86% to -$9738.0 in 2022, then jumped by 30.08% to -$6809.0 in 2023, then surged by 536.95% to $29752.0 in 2024, then slumped by 2484.39% to -$709403.0 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$709403.0, $107242.0, and -$34786.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.